NCT07671079

Brief Summary

The goal of this study is to establish if non-invasive closed-loop neuromodulation is an effective approach to enhance cognitive function in healthy 18-40 years old volunteers. The main questions it aims to answer are:

  • Can closed-loop stimulation increase stimulation effectiveness?
  • Can closed-loop focused ultrasound specifically engage with excitatory or inhibitory neural populations in the target structure as measured through MRS?
  • Can observed stimulation outcomes for FUS be predicted through connectome analysis and computational models of indirect changes? Researchers will compare different closed-loop options to their open-loop counterpart to see if closed-loop approaches can increase efficacy and reduce the variability of the stimulation compared to open-loop approaches. Participants will:
  • Answer some questionnaires at the start of the study and after each intervention session.
  • Undertake a MRI scanning session.
  • Undertake one open-loop FUS session.
  • Undertake one tES session.
  • Undertake one closed-loop FUS sessions involving tES and FUS, followed by a MRI scanning
  • Undertake one sham FUS session
  • Attend one visit in person to assess eligibility through questionnaires and one cognitive task

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Jul 2026Dec 2027

First Submitted

Initial submission to the registry

June 22, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 26, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

June 26, 2026

Status Verified

June 1, 2026

Enrollment Period

1.1 years

First QC Date

June 22, 2026

Last Update Submit

June 22, 2026

Conditions

Keywords

neuromodulationelectrical stimulationtranscranial low-intensity focused ultrasound stimulationclosed-loop neuromodulation

Outcome Measures

Primary Outcomes (11)

  • Change from Baseline in EEG Power in Alpha Band (8-12Hz)

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Change from Baseline in EEG Power in Theta Band (4-7Hz)

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Change from Baseline in EEG Power in Beta Band (13-30Hz)

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Change from Baseline in EEG Power in Gamma Band (31-45Hz)

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Changes from Baseline in EEG-derived spectral power

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Changes from Baseline in Functional connectivity (e.g., through changes in Phase-locked value (PLV))

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Average Reaction time (ms) measured from the Visual Working memory task

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Average Overall accuracy (%) measured from Visual Working Memory task

    Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation

  • Change from Baseline in Target-Region metabolite Concentration measured via Magnetic Resonance Spectroscopy (MRS)

    Baseline (Day 1) to immediately after closed-loop post-stimulation intervention

  • Changes from Baseline in Functional Connectivity calculated from functional Magnetic Resonance Imaging (fMRI)

    Baseline (Day 1) to immediately after closed-loop post-stimulation intervention

  • Changes from Baseline on Structural connectivity metrics derived from multi-shell diffusion MRI (dMRI) tractography

    Baseline (Day 1) to immediately after closed-loop post-stimulation intervention

Secondary Outcomes (1)

  • Structured questionnaire assessing adverse effects of the intervention

    Immediately after stimulation, 24 hours after stimulation and 1 week after stimulation

Study Arms (4)

Open-loop transcranial low-intensity FUS

ACTIVE COMPARATOR

Transcranial low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system

Other: Transcranial low intensity focused ultrasound (FUS)Procedure: Magnetic Resonance Imaging

Closed-loop transcranial low-intensity FUS

EXPERIMENTAL

Closed-loop Transcranial Electrical Stimulation by means of tACS or TI delivered through a Digitimer DS5 for brain entrainment phase-locked on peak or trough to transcranial low intensity FUS delivered to dACC through the NeuroFUS PRO system

Other: Transcranial low intensity focused ultrasound (FUS)Other: transcranial electrical stimulationProcedure: Magnetic Resonance Imaging

tES alone

ACTIVE COMPARATOR

tACS or TI delivered through a Digitimer DS5 for brain entrainment phase-locked on peak or trough

Other: transcranial electrical stimulationProcedure: Magnetic Resonance Imaging

Sham FUS

ACTIVE COMPARATOR

FUS delivered to ventricles or FUS and tACS located on head, one of them on or off depending on sham, or active.

Other: Transcranial low intensity focused ultrasound (FUS)Procedure: Magnetic Resonance Imaging

Interventions

We obtain baseline functional, metabolic and structural information through MRI and MRS scanning

Also known as: MRI
Closed-loop transcranial low-intensity FUSOpen-loop transcranial low-intensity FUSSham FUStES alone

Low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system

Also known as: LIFU, tFUS, TUS
Closed-loop transcranial low-intensity FUSOpen-loop transcranial low-intensity FUSSham FUS

Transcranial electrical stimulation (by means of transcranial alternating current stimulation (tACS) or non-invasive temporal interference (TI) electrical stimulation) using the DS5 isolated bipolar constant current stimulator together connected to a wave generator and with two electrodes for tACS (TI implementation will be carried out with two DS5 systems, separate wave generators and four electrodes).

Also known as: tES
Closed-loop transcranial low-intensity FUStES alone

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study
  • Aged between 18 and 40
  • Good general health
  • Not consume alcohol 48 hours prior study visit
  • Not currently taking any medications (except contraceptive pills) or if on long-term medication for a non-neurological/non-psychiatric condition (r.g. inhalers) to be considered otherwise healthy and stable with no symptoms
  • Be right handedness

You may not qualify if:

  • Inability to complete MRI/FUS/TMS/tES safety questionnaire and / or informed consent process.
  • Current or previous diagnosis of a neurological, neurosurgical, psychiatric disorders.
  • Currently pregnant, breast feeding, or on planned pregnancy.
  • Medication intake (such as beta-blocker, glucocorticoids, anti-depressants, anti-inflammatory drugs in the last 7d).
  • Medication intake (such as beta-blocker, glucocorticoids, anti-depressants) in the last 7d that are likely to affect brain function.
  • Significant use of medication or recreational drugs that affect the nervous system.
  • Excessive consumption of alcohol (\>2 alcohol beverages per day).
  • Known allergy to any required consumables (such as aquasonic gel).
  • History of anaphylaxis to any substance
  • Have tightly coiled, curly or voluminous texture hair type (e.g., hair type 3, 4, or afro hair).
  • Having skin disease or sensitive skin on or close to the head.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nottingham

Nottingham, United Kingdom

Location

Related Publications (7)

  • Zhai Z, Ren L, Song Z, Xiang Q, Zhuo K, Zhang S, Li X, Zhang Y, Jiao X, Tong S, Sun J, Liu D. The efficacy of low-intensity transcranial ultrasound stimulation on negative symptoms in schizophrenia: A double-blind, randomized sham-controlled study. Brain Stimul. 2023 May-Jun;16(3):790-792. doi: 10.1016/j.brs.2023.04.021. Epub 2023 Apr 29. No abstract available.

    PMID: 37121354BACKGROUND
  • Sarica C, Nankoo JF, Fomenko A, Grippe TC, Yamamoto K, Samuel N, Milano V, Vetkas A, Darmani G, Cizmeci MN, Lozano AM, Chen R. Human Studies of Transcranial Ultrasound neuromodulation: A systematic review of effectiveness and safety. Brain Stimul. 2022 May-Jun;15(3):737-746. doi: 10.1016/j.brs.2022.05.002. Epub 2022 May 6.

    PMID: 35533835BACKGROUND
  • Raco V, Bauer R, Tharsan S, Gharabaghi A. Combining TMS and tACS for Closed-Loop Phase-Dependent Modulation of Corticospinal Excitability: A Feasibility Study. Front Cell Neurosci. 2016 May 25;10:143. doi: 10.3389/fncel.2016.00143. eCollection 2016.

    PMID: 27252625BACKGROUND
  • Briley PM, Boutry C, Webster L, Veniero D, Harvey-Seutcheu C, Jung J, Liddle PF, Morriss R. Intermittent theta burst stimulation with synchronised transcranial alternating current stimulation leads to enhanced frontal theta oscillations and a positive shift in emotional bias. Imaging Neurosci (Camb). 2024 Jan 25;2:imag-2-00073. doi: 10.1162/imag_a_00073. eCollection 2024.

    PMID: 40800403BACKGROUND
  • Nakazono H, Ogata K, Takeda A, Yamada E, Oka S, Tobimatsu S. A specific phase of transcranial alternating current stimulation at the beta frequency boosts repetitive paired-pulse TMS-induced plasticity. Sci Rep. 2021 Jun 23;11(1):13179. doi: 10.1038/s41598-021-92768-x.

    PMID: 34162993BACKGROUND
  • Zrenner C, Desideri D, Belardinelli P, Ziemann U. Real-time EEG-defined excitability states determine efficacy of TMS-induced plasticity in human motor cortex. Brain Stimul. 2018 Mar-Apr;11(2):374-389. doi: 10.1016/j.brs.2017.11.016. Epub 2017 Nov 24.

    PMID: 29191438BACKGROUND
  • Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004 Dec 15;72(1):21-8. doi: 10.1016/j.schres.2004.09.008.

    PMID: 15531404BACKGROUND

MeSH Terms

Interventions

Transcranial Direct Current StimulationTESMagnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Marcus Kaiser, PhD

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neuroinformatics

Study Record Dates

First Submitted

June 22, 2026

First Posted

June 26, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

June 26, 2026

Record last verified: 2026-06

Locations